The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer

Systemic comparison of repression activity for miRNA and siRNA associated with different types of target sequences

(2011) Han-Chia Lee et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Involvement ofmiR-30candmiR-301ain immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells

(2011) Nitin Patel et al.   BIOCHEMICAL JOURNAL

MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells

(2011) Syunsuke Noguchi et al.   CANCER LETTERS

Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression

(2011) Michaela Muth et al.   Journal of Translational Medicine

The functional significance of microRNA-145 in prostate cancer

(2010) M S Zaman et al.   BRITISH JOURNAL OF CANCER

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

(2010) T Chiyomaru et al.   BRITISH JOURNAL OF CANCER

Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer

(2010) Markus Becker et al.   CANCER

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway

(2010) O. A. Kent et al.   GENES & DEVELOPMENT

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer

(2010) Erik D. Wiklund et al.   INTERNATIONAL JOURNAL OF CANCER

Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death

(2010) Xiaowei Zhang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

"Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression"

(2010) Michaela Muth et al.   Journal of Translational Medicine

Identification of non-coding RNAs embracing microRNA-143/145 cluster

(2010) Akio Iio et al.   Molecular Cancer

A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects

(2010) Jesper B. Bramsen et al.   NUCLEIC ACIDS RESEARCH

miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness

(2010) M Götte et al.   ONCOGENE

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression

(2009) Frederikke Lihme Egerod et al.   BMC CANCER

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

(2009) L. Dyrskjot et al.   CANCER RESEARCH

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells

(2009) R Spizzo et al.   CELL DEATH AND DIFFERENTIATION

The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease

(2009) L Elia et al.   CELL DEATH AND DIFFERENTIATION

MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells

(2009) Pedro M. Borralho et al.   FEBS Journal

Modulation of microRNA processing by p53

(2009) Hiroshi I. Suzuki et al.   NATURE

Erratum: Corrigendum: Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs

(2009) Aly A Khan et al.   NATURE BIOTECHNOLOGY

A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity

(2009) Jesper B. Bramsen et al.   NUCLEIC ACIDS RESEARCH

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

(2009) M S Ostenfeld et al.   ONCOGENE

p53 represses c-Myc through induction of the tumor suppressor miR-145

(2009) M. Sachdeva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer

(2008) T. Schepeler et al.   CANCER RESEARCH

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH

Regulation of Plasminogen Activator Inhibitor-1 Expression by Tumor Suppressor Protein p53

(2008) Sreerama Shetty et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA and cancer - focus on apoptosis

(2008) Yu Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis

(2008) Kasper Thorsen et al.   MOLECULAR & CELLULAR PROTEOMICS

Epigenetics in Cancer

(2008) Manel Esteller   NEW ENGLAND JOURNAL OF MEDICINE

Systematic Identification of mRNAs Recruited to Argonaute 2 by Specific microRNAs and Corresponding Changes in Transcript Abundance

(2008) David G. Hendrickson et al.   PLoS One